Markets

Market Nav

NOVARTIS INDIA LTD.

NSE Code-
BSE Code500672
ISININE234A01025
IndustryPharmaceuticals

996.50+ 166.05 (20.00%) In BSE

1034421 Volume

904.00 Open Price

830.45 Prev. Close

0.00 (0) Bid. Price (Qty.)

0.00 (0) Offer. Price (Qty.)

996.50 904.00

Today's Low / High

1099.90 744.95

52 Wk Low / High

View Chart

NOVARTIS INDIA LTD.is not traded in NSE

Corporate News

Novartis - Announcement under Regulation 30 (LODR)-Me...

20-Feb-2026|12:04AM

Disclosure under Regulation 30 of SEBI LODR Regulations.

Novartis - Rumour verification - Regulation 30(11)

29-Jan-2026|3:03PM

Clarification regarding incorrect financial figures of Novartis India Limit

Novartis Q3 net profit down 36.78% at Rs 16.09 cr

28-Jan-2026|2:30PM

The company reported standalone net profit of Rs 16.09 crore for the quarte

Novartis - Integrated Filing (Financial) For The Quar...

28-Jan-2026|2:15PM

Integrated Filing (Financial) for the Quarter ended December 31, 2025.

	Promoters 17,450,680	70.68%
	Institutional Investors 202,776	0.82%
	Other Investors 1,440,251	5.83%
	General Public 5,597,090	22.67%

Peer Comparison

Company Name	Price (₹)	Market Cap(₹ Cr)
Aarey Drug	78.52	222.64
Aarti Drug	372.30	3,397.98
Aarti Pharma	698.75	6,334.71
Abbott India	26,295.00	55,875.04
Accent Micro	335.00	803.63

Scheme Name	Value (₹ Cr)	Holding (%)
Motilal..	0.02	0.04
Bandhan..	0.01	0.04
Motilal..	0.00	0.00

Date	Purpose
28/01/2026	Quarterly Results
28/10/2025	Quarterly Results
29/07/2025	Quarterly Results
09/05/2025	Audited Results & F..
28/01/2025	Quarterly Results

Login

Markets

NOVARTIS INDIA LTD.

Company Information

Management

Incorporation Year

Registered Address

Registrar Office

Email

Website

Listing

Corporate News

Novartis - Announcement under Regulation 30 (LODR)-Me...

Novartis - Rumour verification - Regulation 30(11)

Novartis Q3 net profit down 36.78% at Rs 16.09 cr

Novartis - Integrated Filing (Financial) For The Quar...

Share Holding Pattern

Peer Comparison

MF Holding

Board Meetings